The National Retail Federation increased its Christmas retail sales growth forecast to 3.8 percent year-over-year from its earlier 2.8 percent prediction — and if history is any indicator, New Jersey retailers will see that same benefit.

As shareholders of Brooklyn Federal Bancorp Inc. prepare to vote Thursday on the $11 million merge with Investors Bancorp Inc., the head of New Jersey's third largest bank is hopeful the deal will get done.

Beginning next week, Exclaim Mobility will rebrand its corporate image as Snap MyLife, a move President and CEO Jiren Parikh said signifies the next step in expanding the company's offerings.

Before the Federal Communications Commission could approve a recent $3.6 billion bandwidth acquisition, Verizon Wireless announced Friday another purchase of Advance Wireless Services spectrum licenses,...

Cashing in securities; Texas acquisition; solar to stadium.

The halting of the ARC rail tunnel project last year has allowed NJ Transit to focus on areas such as customer service, expanding existing rail lines and finding alternative revenue sources, the head of the agency told business leaders Friday.

Mark M. Murphy, the new president of Leadership New Jersey, made his first formal remarks Thursday evening at the nonprofit's annual awards dinner at the Princeton Marriott at Forrestal.

NJBIZ has learned that Princeton-based Withum, Smith & Brown P.C. one of the state's top accounting and consulting firms, plans to announce Monday that it will merge with EisnerLubin LLP, of New York. Terms of the deal have not been disclosed.

The board of trustees at Montclair State University announced Friday approval for the creation of a new school, the School of Communications and Media, which will be part of the College of Arts.

Office holiday parties are often the stuff lawsuits are made of. When there is too much drinking, people can let their guard down — flirting, telling inappropriate jokes, using foul language or buying distasteful gag gifts.

Extinguishing debt; seniors for solar; amending clinical trial.